sponsored
PatientsVille.com Logo

PatientsVille

Lisinopril and Acetaminophen

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectLisinoprilAcetaminophen
COMPLETED SUICIDE0.6% 3.6%
NAUSEA3.3% 3%
DRUG INEFFECTIVE3.2% 2.2%
FATIGUE3.1% 2.6%
DIARRHOEA2.8% 2.1%
DYSPNOEA2.7% 2.2%
TOXICITY TO VARIOUS AGENTS0.4% 2.7%
DIZZINESS2.5% 1.7%
PAIN2.2% 2.4%
HEADACHE2.1% 2.3%
VOMITING1.8% 2.3%
DEATH1.1% 2.2%
PYREXIA0.9% 2.1%
ASTHENIA1.9% 1.7%
FALL1.6% 1.6%
PNEUMONIA1.2% 1.6%
ARTHRALGIA1.5% 1.5%
MALAISE1.5% 1.4%
HYPOTENSION1.3% 1.5%
WEIGHT DECREASED1.5% 1%
COUGH1.5% 1%
OVERDOSE0% 1.5%
PAIN IN EXTREMITY1.4% 1.2%
HYPERTENSION1.4% 1%
MYOCARDIAL INFARCTION1.4% 0.6%
RASH1.3% 1.2%
PRURITUS1.3% 1%
ANGIOEDEMA1.3% 0%
CHEST PAIN1.2% 1%
OFF LABEL USE1.2% 1%
INSOMNIA1.2% 0.9%
ABDOMINAL PAIN0.9% 1.2%
BLOOD GLUCOSE INCREASED1.2% 0%
ANXIETY1.1% 1.1%
BACK PAIN1.1% 1.1%
ANAEMIA1% 1.1%
DEPRESSION1.1% 0.9%
CARDIAC FAILURE CONGESTIVE1.1% 0%
DRUG DOSE OMISSION1.1% 0%
RENAL FAILURE1% 1%
CONSTIPATION1% 0.9%
CONFUSIONAL STATE0.8% 1%
DEHYDRATION1% 0.8%
DECREASED APPETITE1% 0.8%
BLOOD PRESSURE INCREASED1% 0.7%
SOMNOLENCE0.7% 1%
FEELING ABNORMAL1% 0.6%
CEREBROVASCULAR ACCIDENT1% 0.5%
FLUSHING1% 0%
DRUG INTERACTION0.7% 0.9%
URINARY TRACT INFECTION0.7% 0.9%
CONDITION AGGRAVATED0.7% 0.9%
GAIT DISTURBANCE0.9% 0.7%
WEIGHT INCREASED0.9% 0.7%
ACUTE KIDNEY INJURY0.9% 0.7%
DRUG HYPERSENSITIVITY0.9% 0.6%
MUSCLE SPASMS0.9% 0.6%
CARDIAC ARREST0% 0.9%
CARDIO-RESPIRATORY ARREST0% 0.9%
ABDOMINAL PAIN UPPER0.8% 0.8%
OEDEMA PERIPHERAL0.8% 0.8%
RENAL FAILURE ACUTE0.8% 0.7%
MYALGIA0.8% 0.6%
GASTROINTESTINAL HAEMORRHAGE0.8% 0.6%
PARAESTHESIA0.8% 0.5%
HAEMOGLOBIN DECREASED0.5% 0.8%
SEPSIS0% 0.8%
INTENTIONAL OVERDOSE0% 0.8%
HYPOAESTHESIA0.7% 0.6%
ATRIAL FIBRILLATION0.7% 0.6%
TREMOR0.7% 0.6%
CHILLS0.4% 0.7%
THROMBOCYTOPENIA0% 0.7%
ALANINE AMINOTRANSFERASE INCREASED0% 0.7%
SINUSITIS0% 0.7%
DRUG TOXICITY0% 0.7%
INFUSION RELATED REACTION0% 0.7%
PULMONARY EMBOLISM0% 0.7%
ABDOMINAL DISCOMFORT0.7% 0%
INJECTION SITE PAIN0.7% 0%
ALOPECIA0.7% 0%
HYPERHIDROSIS0.6% 0.6%
ERYTHEMA0.6% 0.6%
NASOPHARYNGITIS0.6% 0.6%
LOSS OF CONSCIOUSNESS0.6% 0.6%
CHRONIC KIDNEY DISEASE0.6% 0.5%
MUSCULAR WEAKNESS0.6% 0.5%
PERIPHERAL SWELLING0.6% 0.5%
PLATELET COUNT DECREASED0% 0.6%
VISION BLURRED0.6% 0%
PRODUCT QUALITY ISSUE0.6% 0%
SYNCOPE0.6% 0%
DRUG ABUSE0% 0.6%
TACHYCARDIA0% 0.6%
RESPIRATORY ARREST0% 0.6%
ASPARTATE AMINOTRANSFERASE INCREASED0% 0.6%
DEEP VEIN THROMBOSIS0% 0.6%
NEUTROPENIA0% 0.6%
HEART RATE INCREASED0.5% 0.5%
HYPERSENSITIVITY0.5% 0.5%
URTICARIA0.5% 0.5%
JOINT SWELLING0.5% 0.5%
ACUTE HEPATIC FAILURE0% 0.5%
INFECTION0% 0.5%
RHEUMATOID ARTHRITIS0% 0.5%
RESPIRATORY FAILURE0% 0.5%
INTERNATIONAL NORMALISED RATIO INCREASED0% 0.5%
METABOLIC ACIDOSIS0% 0.5%
PLEURAL EFFUSION0% 0.5%
GENERAL PHYSICAL HEALTH DETERIORATION0% 0.5%
DIABETES MELLITUS0.5% 0%
MEMORY IMPAIRMENT0.5% 0%
DYSPHAGIA0.5% 0%
PALPITATIONS0.5% 0%
GASTROOESOPHAGEAL REFLUX DISEASE0.5% 0%
CONTUSION0.5% 0%
CORONARY ARTERY DISEASE0.5% 0%
HYPERKALAEMIA0.5% 0%
DYSPEPSIA0.5% 0%
INCORRECT DOSE ADMINISTERED0.5% 0%
BLOOD CREATININE INCREASED0% 0.5%
CHRONIC OBSTRUCTIVE PULMONARY DISEASE0.4% 0%
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION0.4% 0%
NEUROPATHY PERIPHERAL0.4% 0%
BRONCHITIS0.4% 0%
DYSGEUSIA0.4% 0%
BALANCE DISORDER0.4% 0%

New treatments are found every day. View current Lisinopril research studies and Acetaminophen clinical trials

1